Peter Schlenke

4.9k total citations
150 papers, 3.3k citations indexed

About

Peter Schlenke is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Peter Schlenke has authored 150 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 34 papers in Immunology and 26 papers in Molecular Biology. Recurrent topics in Peter Schlenke's work include Blood groups and transfusion (25 papers), Blood transfusion and management (23 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Peter Schlenke is often cited by papers focused on Blood groups and transfusion (25 papers), Blood transfusion and management (23 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Peter Schlenke collaborates with scholars based in Germany, Austria and United States. Peter Schlenke's co-authors include Holger Kirchner, Jan Kramer, Ulrich Lindner, Christoph Frohn, Holger Hennig, Walter Sibrowski, Jürgen Rohwedel, Jürgen Luhm, Isabel Dorn and D. Hartwig and has published in prestigious journals such as Blood, Annals of Neurology and The FASEB Journal.

In The Last Decade

Peter Schlenke

142 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Schlenke Germany 32 870 664 644 501 481 150 3.3k
Kenji Ikebuchi Japan 29 941 1.1× 990 1.5× 868 1.3× 187 0.4× 477 1.0× 118 3.6k
Fabrice Cognasse France 37 681 0.8× 1.8k 2.7× 1.3k 2.0× 350 0.7× 237 0.5× 142 5.0k
Ashish Jain India 28 774 0.9× 266 0.4× 1.2k 1.9× 889 1.8× 348 0.7× 139 3.6k
Armando Gabrielli Italy 41 1.3k 1.5× 610 0.9× 1.7k 2.7× 560 1.1× 458 1.0× 174 6.5k
Zaher K. Otrock Lebanon 26 770 0.9× 1.1k 1.7× 768 1.2× 280 0.6× 376 0.8× 116 3.0k
Robert G. Schaub United States 40 1.2k 1.4× 1.6k 2.5× 1.5k 2.4× 707 1.4× 363 0.8× 154 5.5k
Francesco Indiveri Italy 41 823 0.9× 530 0.8× 3.2k 4.9× 615 1.2× 604 1.3× 215 5.9k
Bjarne Kuno Møller Denmark 24 541 0.6× 340 0.5× 552 0.9× 365 0.7× 220 0.5× 114 2.3k
Elisabeth M. Cramer France 38 1.3k 1.5× 2.6k 4.0× 1.1k 1.6× 434 0.9× 809 1.7× 119 5.1k
Elizabeth E. Gardiner Australia 48 1.3k 1.5× 3.1k 4.7× 1.1k 1.8× 1.1k 2.2× 363 0.8× 178 6.6k

Countries citing papers authored by Peter Schlenke

Since Specialization
Citations

This map shows the geographic impact of Peter Schlenke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schlenke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schlenke more than expected).

Fields of papers citing papers by Peter Schlenke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schlenke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schlenke. The network helps show where Peter Schlenke may publish in the future.

Co-authorship network of co-authors of Peter Schlenke

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Schlenke. A scholar is included among the top collaborators of Peter Schlenke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Schlenke. Peter Schlenke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sconocchia, Tommaso, et al.. (2025). Engineered cytokine-expressing MSCs support ex vivo culture of human HSPCs and AML cells. Experimental Hematology. 147. 104790–104790.
2.
Sourij, Caren, Martin Stradner, Peter Schlenke, et al.. (2025). IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes. European Journal of Immunology. 55(12). e70112–e70112.
3.
Schlenke, Peter, et al.. (2024). Characterization of three novel HLA class I alleles, HLA‐A*31:01:02:56, HLA‐B*35:588 and HLA‐B*57:153. HLA. 103(1). e15338–e15338. 2 indexed citations
4.
Herrmann, Markus, Sieglinde Zelzer, Étienne Cavalier, et al.. (2023). Functional Assessment of Vitamin D Status by a Novel Metabolic Approach: The Low Vitamin D Profile Concept. Clinical Chemistry. 69(11). 1307–1316. 15 indexed citations
5.
Bernecker, Claudia, Dagmar Kolb, Martin Trötzmüller, et al.. (2022). Membrane Properties of Human Induced Pluripotent Stem Cell-Derived Cultured Red Blood Cells. Cells. 11(16). 2473–2473. 5 indexed citations
6.
Ediriwickrema, Asiri, Karl Kashofer, Christine Beham‐Schmid, et al.. (2021). Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells. Blood. 138(Supplement 1). 2160–2160. 1 indexed citations
7.
Richtig, Erika, Birgit Hirschmugl, Mariangela Garofalo, et al.. (2021). MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy. International Journal of Molecular Sciences. 22(21). 11318–11318. 1 indexed citations
8.
Bernecker, Claudia, et al.. (2021). Biomechanics of Ex Vivo-Generated Red Blood Cells Investigated by Optical Tweezers and Digital Holographic Microscopy. Cells. 10(3). 552–552. 19 indexed citations
9.
Lichtenegger, Sabine, Barbara Kleinhappl, Claudia Bernecker, et al.. (2020). Burkholderia pseudomallei triggers canonical inflammasome activation in a human primary macrophage-based infection model. PLoS neglected tropical diseases. 14(11). e0008840–e0008840. 5 indexed citations
10.
Weidner, Lisa, Lukas Weseslindtner, Camilla Drexler, et al.. (2020). Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. Journal of Clinical Virology. 129. 104540–104540. 93 indexed citations
11.
Bernecker, Claudia, Mania Ackermann, Nico Lachmann, et al.. (2019). Enhanced Ex Vivo Generation of Erythroid Cells from Human Induced Pluripotent Stem Cells in a Simplified Cell Culture System with Low Cytokine Support. Stem Cells and Development. 28(23). 1540–1551. 43 indexed citations
12.
Drexler, Camilla, Susanne Macher, Magdalena Holter, et al.. (2019). High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial. Clinical Nutrition. 39(3). 737–745. 20 indexed citations
13.
Schöler, Hans R., et al.. (2017). Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells. Transfusion Medicine and Hemotherapy. 44(3). 143–150. 17 indexed citations
14.
Kramer, Jan, Francesco Dazzi, Massimo Dominici, Peter Schlenke, & Wolfgang Wagner. (2012). Clinical Perspectives of Mesenchymal Stem Cells. Stem Cells International. 2012. 1–3. 16 indexed citations
15.
Rotter, Nicole, Peter Schlenke, Ulrich Lindner, et al.. (2008). Isolation and Characterization of Adult Stem Cells from Human Salivary Glands. Stem Cells and Development. 17(3). 509–518. 95 indexed citations
16.
Härtel, Christoph, Peter Schlenke, Lutz Fricke, et al.. (2003). Individual Variability in Cyclosporin A Sensitivity: The Assessment of Functional Measures on CD28-Mediated Costimulation of Human Whole Blood T Lymphocytes. Journal of Interferon & Cytokine Research. 23(2). 91–99. 10 indexed citations
17.
Sheikhzadeh, Sara, et al.. (2001). Improvement of the Precision in CFU-GM and BFU-E Counting by Flow Cytometry-Based Standardization of Short-Term Culture Assays. Journal of Hematotherapy & Stem Cell Research. 10(6). 881–885. 4 indexed citations
18.
Klüter, Harald, et al.. (2001). Results of vitrectomy and the no-touch-technique using autologous adjuvants in macular hole treatment. International Ophthalmology. 24(3). 151–159. 25 indexed citations
19.
Hennig, Holger, et al.. (2000). Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies. Journal of Virological Methods. 84(2). 181–190. 19 indexed citations
20.
Mueller, Peter P., Peter Schlenke, Manfred Nimtz, Harald S. Conradt, & H. Häuser. (1999). Recombinant glycoprotein product quality in proliferation-controlled BHK-21 cells. Biotechnology and Bioengineering. 65(5). 529–536. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Ikebuchi Breakdown of academic impact, for papers by Fabrice Cognasse Breakdown of academic impact, for papers by Ashish Jain Breakdown of academic impact, for papers by Armando Gabrielli Breakdown of academic impact, for papers by Zaher K. Otrock Breakdown of academic impact, for papers by Robert G. Schaub Breakdown of academic impact, for papers by Francesco Indiveri Breakdown of academic impact, for papers by Bjarne Kuno Møller Breakdown of academic impact, for papers by Elisabeth M. Cramer Breakdown of academic impact, for papers by Elizabeth E. Gardiner
Rankless by CCL
2026